PUBLICATIONS · 31826360
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- N Engl J Med
- Publication date
- 2020 Feb 6
- First author
- Slamon DJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- N Engl J Med. 2020 Jun 4;382(23):e85. doi: 10.1056/NEJMc2004229.
- note
- Source null
- related pmid
- 32492318
- relationship
- Comment in
Authors and identifiers
- name
- Slamon DJ
- type
- Author
- name
- Neven P
- type
- Author
- name
- Chia S
- type
- Author
- name
- Fasching PA
- type
- Author
- name
- De Laurentiis M
- type
- Author
- name
- Im SA
- type
- Author
- name
- Petrakova K
- type
- Author
- name
- Bianchi GV
- type
- Author
- name
- Esteva FJ
- type
- Author
- name
- Martín M
- type
- Author
- name
- Nusch A
- type
- Author
- name
- Sonke GS
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Slamon DJ
- type
- Author
- name
- Neven P
- type
- Author
- name
- Chia S
- type
- Author
- name
- Fasching PA
- type
- Author
- name
- De Laurentiis M
- type
- Author
- name
- Im SA
- type
- Author
- name
- Petrakova K
- type
- Author
- name
- Bianchi GV
- type
- Author
- name
- Esteva FJ
- type
- Author
- name
- Martín M
- type
- Author
- name
- Nusch A
- type
- Author
- name
- Sonke GS
- type
- Author
- bibliography ids
- nci-bib-bfd36526b6ab02b59b5e42ca
- book metadata
- content sha256
- 56d30979ae49e86e980dcda1af1a35f2cd9305ee466bea52cb58c04fc39b5676
- document type
- citation
- dois
- 10.1056/NEJMoa1911149
- electronic publication date
- display
- 2019 Dec 11
- precision
- day
- year
- 2019
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:31826360
- immutable id
- pubmed:31826360@56d30979ae49e86e980dcda1af1a35f2cd9305ee466bea52cb58c04fc39b5676
- journal
- abbreviation
- N Engl J Med
- issn electronic
- 1533-4406
- issn print
- 0028-4793
- issue
- 6
- name
- The New England journal of medicine
- nlm unique id
- 0255562
- pages
- 514-524
- volume
- 382
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- N Engl J Med. 2020 Jun 4;382(23):e85. doi: 10.1056/NEJMc2004229.
- note
- Source null
- related pmid
- 32492318
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 31826360
- provenance
- batch id
- 4c5003fbb78890e89ae1
- provider
- NCBI PubMed ESummary
- record sha256
- 9789799ade921f404a2976bd14c1a9cfd883fb50ef1be6c9796bf7f17a6e48ab
- response sha256
- 890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
- retrieved at
- 2026-09-09T23:47:48.270700+00:00
- publication date
- display
- 2020 Feb 6
- precision
- day
- year
- 2020
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer.
Preserved source evidence · Not medical advice
Triangle